Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Antibodies

Anti-CD28 [TGN1412 (Theralizumab)]

Product Sizes
1 mg
Was £2163.00 £2055.00
AB04902-10-0-BT-1MG
About this Product
SKU:
AB04902-10-0-BT
Additional Names:
T-cell-specific surface glycoprotein CD28; TP44; TGN1112; 5.11A1; CD28-SuperMAB; TAB08; 9D7
Buffer:
PBS
translate.label.attr.clone:
TGN1412 (Theralizumab)
Clonality:
Recombinant Monoclonal
Extra Details:
This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques.
Formulation:
PBS only.
Host:
Human
Immunogen:
The original mouse antibody 5.11A1 was generated by immunizing BALB/c mice with recombinant human CD28-Fc fusion protein and boosted with B lymphoma cell line transfected with human CD28. Later on the CDRs of the original mouse antibody were cloned into human IgG1 framework regions to obtain the humanized antibody.
Isotype:
IgG1
Purification:
Purified
Reactivities:
Human, Non-human Primate
Shipping Conditions:
Blue Ice
Specificity:
The antibody is specific for human CD28. CD28 is one of the proteins expressed on T cells that provide co-stimulatory signals required for T cell activation and survival. T cell stimulation through CD28 in addition to the T-cell receptor (TCR) can provide a potent signal for the production of various interleukins.
Storage Conditions:
2-8[o]C, -20[o]C aliquoted. Avoid freeze/thaw cycles.
Supplier:
Absolute Antibody
Type:
Antibody: Recombinant Antibodies